TNF and Alzheimer disease: In both NC- and FOXQ1 siRNA–treated PC-12 cellular AD models, Si-PTGS2 reduced TNF-α (Figure 12D), IL-1β (Figure 12E), and IL-6 (Figure 12F) levels.